Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Patheon, by Thermo Fisher Scientific, is transforming the way pharmaceuticals are developed and manufactured with a streamlined, end-to-end approach for biotechnology and pharmaceutical companies of all sizes. From drug substances to drug products, from development to manufacturing, from small molecules to large molecules, and across various dosage forms—including oral solid dose, softgels, and steriles—we are the CDMO you need by your side.
Patheon offers a comprehensive range of services spanning all drug development phases, unmatched by any other CDMO in the industry. Gain instant access to a fully integrated global network of facilities, supported by over 8,000 scientific and professional staff members and backed by more than 40 years of experience and innovation. With an unrivaled track record for quality and on-time performance, Patheon is your partner in achieving pharmaceutical excellence.
Download our pharma services overview brochure to learn more about our end-to-end CDMO capabilities.